Skip to main content

Table 1 Baseline characteristics of participants in ARIC and AASK

From: Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney DiseaseĀ and Hypertension

Ā 

ARIC*(Nā€‰=ā€‰4046)

AASK (Nā€‰=ā€‰694)

Ā 

Mean (SD)

Mean (SD)

Age, years

75.7 (5.2)

54.5 (10.7)

Woman, %

2177(53.8%)

267 (38.5%)

Black, %

695 (17.2%)

694(100%)

Heart disease, %

753 (18.6%)

352 (50.7%)

Diabetes, %

1201 (29.7%)

0 (0%)

Total Cholesterol, mg/dL

179.0 (41.7)

212.0 (45.9)

High-density lipoprotein, mg/dL

51.2 (13.8)

48.2 (16.0)

Systolic blood pressure, mmHg

130.2 (18.0)

150.9 (23.8)

Body mass index, kg/m2

28.7 (5.5)

30.5 (6.4)

Glucose, mg/dL

114.0 (28.7)

94.2(15.4)

Antihypertensive medication, %

2719 (67.2%)

694 (100%)

Glomerular filtration rate**, mL/min/1.73m2

65 (18)

46 (13)

24Ā h urine protein levels (mg/day)***

n.a

109 (41; 561)

Albumin-to-creatinine ratio (mg/g)***

11 (6; 23)

n.a

  1. * visit 5; ** estimated GFR for ARIC and measured GFR for AASK; *** Median (1st; 3rd quartile) instead of mean (SD)